Research study Program year 2025 Source: CMS Open Payments

CLL 1L Fit GV FCR Br

Research payments

$1,301,444

239 payments

Through program year 2025, $1,301,444 in research payments was reported against CLL 1L Fit GV FCR Br, across 239 payments.

Paid by (largest first)
Genentech, Inc.; Hoffmann-La Roche Limited; F. Hoffmann-La Roche AG
ClinicalTrials.gov
No trial number was reported for this study

By program year

6 rows
Year Kind Amount Payments
2025 Research $46,217 15
2024 Research $114,773 68
2023 Research $129,768 19
2022 Research $250,467 67
2021 Research $605,323 58
2020 Research $154,897 12

Breakdown

Who paid Research payments · program years 2020–2025
  1. Genentech, Inc. $1,285,989 230 payments
  2. Hoffmann-La Roche Limited $9,883 1 payment
  3. F. Hoffmann-La Roche AG $5,572 8 payments
Who received the money Research payments · program years 2020–2025
  1. United States Oncology Research LLC Organisation paid for research $432,435 103 payments
  2. Physicians Reliance Network US Oncology Research INC Organisation paid for research $419,973 32 payments
  3. University Of Tennessee Medical Cent Teaching hospital · TN $164,004 16 payments
  4. American Oncology Partners Organisation paid for research $74,409 6 payments
  5. Texas Oncology Southwest Fort Worth Organisation paid for research $42,925 8 payments
  6. St Vincent Healthcare Teaching hospital · MT $41,305 2 payments
  7. Texas Oncology, P.A. Organisation paid for research $29,038 3 payments
  8. Oncology & Hematology Associates Of Southwest Virginia Inc. Organisation paid for research $25,398 34 payments
  9. Maryland Oncology Hematology PA Organisation paid for research $13,175 3 payments
  10. New York Oncology Hematology Hudson Organisation paid for research $11,900 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record